Alice Dragomir is an Associate Professor at the Faculty of
Pharmacy, University of Montreal (UdeM), Canada. She is a health economist and
biostatistician with an MSc in statistics and a PhD in pharmacoepidemiology and
pharmacoeconomics from UdeM. Prior to joining UdeM, she was an Associate
Professor at the Faculty of Medicine of McGill University. Her current research
is focused on the clinical and economic evaluation of different treatment
strategies offered to patients with urological cancers. She has extensive
experience conducting studies based on administrative healthcare databases,
such as RAMQ and Med-Echo, and conducting economic evaluations.
Alice Dragomir is an Associate Professor at the Faculty of
Pharmacy, University of Montreal (UdeM), Canada. She is a health economist and
biostatistician with an MSc in statistics and a PhD in pharmacoepidemiology and
pharmacoeconomics from UdeM. Prior to joining UdeM, she was an Associate
Professor at the Faculty of Medicine of McGill University. Her current research
is focused on the clinical and economic evaluation of different treatment
strategies offered to patients with urological cancers. She has extensive
experience conducting studies based on administrative healthcare databases,
such as RAMQ and Med-Echo, and conducting economic evaluations.